0001437749-23-003836.txt : 20230217 0001437749-23-003836.hdr.sgml : 20230217 20230217173055 ACCESSION NUMBER: 0001437749-23-003836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230215 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Andrew D. CENTRAL INDEX KEY: 0001811872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 23644212 MAIL ADDRESS: STREET 1: 2000 POWELL STREET STREET 2: SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rdgdoc.xml FORM 4 X0306 4 2023-02-15 1 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001811872 Jones Andrew D. C/O NOVABAY PHARMACEUTICALS, INC. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 1 CFO The reporting person departed from his position at NovaBay Pharmaceuticals, Inc., effective February 15, 2023. As a result, the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of NovaBay Pharmaceuticals, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5. /s/ Andrew D. Jones 2023-02-17